Abstract:Importance: The American Heart Association ideal cardiovascular health (CVH) score is associated with the risk of cardiovascular disease (CVD) and mortality. However, it is unclear whether the number of years spent in ideal CVH is associated with morbidity or with mortality. Objective: To evaluate whether living longer with a higher CVH score in midlife is associated with lower risk of hypertension, diabetes, chronic kidney disease, CVD and its subtypes (coronary heart disease, stroke, congestive heart failure, and peripheral artery disease), or all-cause mortality in later life. Design, setting, and participants: This prospective cohort study used data from 1445 participants from 1991 to 2015 who participated in the community-based Framingham Heart Study Offspring investigation conducted in Massachusetts. The CVH scores of participants were assessed at examination cycles 5, 6, and 7 (1991-1995; 1995-1998; and 1998-2001, respectively). Individuals were excluded from analyses of the association between duration of CVH score and outcomes if they had the outcome of interest at the seventh examination. The median follow-up was approximately 16 years. Data were analyzed from April 2018 to October 2019. The CVH score categories were poor for scores 0 to 7, intermediate for scores 8 to 11, and ideal for scores 12 to 14. A composite score was derived based on smoking status, diet, physical activity, resting blood pressure levels, body mass index, fasting blood glucose levels, and total serum cholesterol levels. Main outcomes and measures: Number of events and number at risk for each main outcome, including incident hypertension, diabetes, chronic kidney disease, CVD, and all-cause mortality, after the seventh examination. Results: Of 1445 eligible participants, the mean (SD) age was 60 (9) years, and 751 (52%) were women. Number of events/number at risk for each main outcome after the seventh examination were 348/795 for incident hypertension, 104/1304 for diabetes, 198/918 for chronic kidney disease, 210/1285 for CVD, and 300/1445 for all-cause mortality. At the seventh examination, participants mostly had poor (568 [39%]) or intermediate (782 [54%]) CVH scores. For each antecedent (before examination cycle 7) 5-year duration that participants had intermediate or ideal CVH, they were less likely to develop adverse outcomes (hazards ratios of 0.67 [95% CI, 0.56-0.80] for incident hypertension, 0.73 [95% CI, 0.57-0.93] for diabetes, 0.75 [95% CI, 0.63-0.89] for chronic kidney disease, 0.73 [95% CI, 0.63-0.85] for CVD, and 0.86 [95% CI, 0.76-0.97] for all-cause mortality) relative to living the same amount of time in poor CVH (referent group). No effect modification was observed by age or by sex. Conclusions and relevance: These results suggest that more time spent in better CVH in midlife may have salutary cardiometabolic benefits and may be associated with lower mortality later in life.

Association between ideal cardiovascular health and abnormal glucose metabolism in the elderly: evidence based on real-world data

Ideal Cardiovascular Health in Chinese Urban Population.

Glucose dysregulation and subclinical cardiac dysfunction in older adults: The Cardiovascular Health Study

Abstract 4121568: the Influence of Cardiovascular Health on Atherosclerotic Cardiovascular Disease Progression and Life Expectancy among Individuals with Type 2 Diabetes

The association of ideal cardiovascular health and its change with subclinical atherosclerosis according to glucose status: A prospective cohort study

Association of the Duration of Ideal Cardiovascular Health Through Adulthood With Cardiometabolic Outcomes and Mortality in the Framingham Offspring Study

Effect Of Cardiorespiratory Fitness On Blood Glucose Trajectory With Aging: A Cohort Study Of Japanese Men

Associations Of Vascular Risk With Cognition, Brain Glucose Metabolism, And Clinical Progression In Cognitively Intact Elders

The Impact of Lipid and Glucose Metabolism Disorders on Geriatric Syndromes

Ideal cardiovascular health index and high-normal blood pressure in elderly people: evidence based on real-world data

High “Normal” Blood Glucose Is Associated with Decreased Brain Volume and Cognitive Performance in the 60s: The PATH through Life Study

Frailty, Body Composition, and Glycemic Control in Older Adults with Type 2 Diabetes

Ideal Cardiovascular Health Predicts Functional Status Independently of Vascular Events: The Northern Manhattan Study

Clinical characteristics of glucose metabolism disorders in middle-aged and elder population

Resting Heart Rate and Impaired Glucose Regulation in Middle-Aged and Elderly Chinese People: A Cross-Sectional Analysis

Associations of Glycemic Measures in the Normal Range with All-Cause Mortality in the Absence of Traditional Risk Factors.

Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program

Association of β-cell function and cognitive impairment in patients with abnormal glucose metabolism

Association between uric acid to high-density lipoprotein cholesterol ratio and chronic kidney disease among Chinese middle-aged and older adults with abnormal glucose metabolism: a nationwide cohort study

Association of ideal cardiovascular health and history of gestational diabetes mellitus in NHANES 2007-2018

The associations among glycemic control, heart variability, and autonomic brain function in healthy individuals: Age- and sex-related differences